Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and to create a database of genetic information for commercial and academic research ... Show More
Oct 7
The Trouble with Tech Companies (and Their Strategies)
Cory Doctorow, author and digital rights advocate, argues that big tech companies from Facebook to Google and beyond have evolved - or devolved - in a disappointing way. He says that many large tech companies begin with a good product, but that over time they prioritize first bus ... Show More
26m 30s
Sep 30
How to Lead with Courage in Chaotic Times
Courage involves taking bold action despite uncertainty and fear. In a volatile business environment, it's hard to be brave. But Ranjay Gulati, a professor at Harvard Business School, says that there are strategies any of us can use to get improve our ability to make smart bets o ... Show More
32m 9s
Sep 23
Steven Pinker on Speculation Bubbles, Super Bowl Ads, and What Leaders Need to Know About Group Psychology
As a leader, psychology is fundamental to your success - whether that means understanding consumer behavior, team dynamics, or even your own biases and blind spots. Harvard professor Steven Pinker says that an important phenomena to understand is that of common knowledge and its ... Show More
27m 29s
Apr 2024
301: Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise
Oruka Therapeutics CEO Lawrence Klein joins us to discuss how his company raised its first round of financing before competing with major players in the inflammation space. We also discuss the latest news in the life sciences, including the end of the Amylyx ALS saga, another use ... Show More
31m 37s
Aug 2021
372: Biotech Billionaire Anne Wojcicki, Cofounder and CEO of 23andMe
You’ve heard data has the power to make or break a business. Nobody knows this more than Anne Wojcicki, co-founder of biotech giant 23andMe. After 15 years of leveraging data to build a game-changing company, Wojcicki made headlines this summer when she became the latest self-mad ... Show More
55m 20s
May 2023
Strategy& Insider Episode 21 - Working across the silos in the healthcare ecosystem
Conversation with Sarah Lidé
Sarah Lidé is the Deputy CEO of Medicon Village Innovation, which is the largest science park in Scandinavia focused on life science, based in Lund. Working at the intersection of academia, corporate players and healthcare providers, she is an expert ... Show More
50m 18s
Nov 2020
#34: How I Became Brave Enough: My First Steps as an Entrepreneur feat. Sasha Shillcutt, MD, MS
Dr. Sasha Shillcutt is the CEO & Founder of Brave Enough, a company that empowers and teaches professional women to lead. She is a well published researcher in cardiac anesthesiology and gender equity, author, and international speaker. In 2016, she was awarded the national Ameri ... Show More
28m 17s
Apr 2021
Paloma Fernández Pérez. "The Emergence of Modern Hospital Management and Organisation in the World 1880s-1930s" (Emerald, 2021)
The Emergence of Modern Hospital Management and Organisation in the World 1880s-1930s (Emerald, 2021) uses a range of empirical evidence and case studies drawn from previously unpublished archival sources to offer one of the first international comparative studies on the transfor ... Show More
49m 1s
Sep 2023
377: The Fourth-Generation CEO of Premier Dental, Julie Charlestein — How to Create a Healthy Succession Plan
Welcome to Strategy Skills episode 377, an interview with the author of How to Lead Your Family Business: Excelling Through Unexpected Crises, Choices, and Challenges, Julie Charlestein. In this book, Julie gets vulnerable about her experience as an emerging leader and ultimately ... Show More
38m 26s
Jul 2017
Genomics, Machine Learning, and the Future of Big Data in Medicine | Eric Schadt
In Episode 15 of Hidden Forces, host Demetri Kofinas speaks with Dr. Eric Schadt. Eric Schadt is founder and CEO of Sema4, as well as Dean of Precision Medicine at the Icahn School of Medicine at Mount Sinai. During the course of his 20-year career, Dr. Eric Schadt has built gene ... Show More
1h 4m